good morning, Matt, you, everyone. Thank and
by increased growth X% products year-over-year. revenue our biologics total X% quarter, second of in by year-over-year, the For led
needed of More importantly, becoming a this on was positive indication for our -- highest more start who demand delivering remain our are patients market achieved life-altering on year-over-year revenue a that favorable, look Xtant who basis, focused since spine open care. positions lines. the a environment, while pandemic, Under to revenue we the much to sequential revenue both products opportunities took quarter challenging multiple trends other and even growth passing production on under procedures due and
elective off we in and the starting recall and spine overall other of review resuming but COVID-XX, slowly the quarter due the to with performance conditions, market surgical that year this of the up first first variant quarter. our ramped procedures started As of middle of Omicron the spread
quarter this allograph selling was by a the generated during OsteoVive particularly and second more our factor cellular a our quarter, from product. product, for procedures. the The -- demand OsteoFactor, elective marrow-derived We Plus, normalized second throughout biologics strong environment a newer channels products led growth
expansion; three, opportunities organic believe our our network roadmap that one, in future new a acquisitions. us adjacent a two, introductions; market The and drive good strength As years. product in penetration; will new are strategic growth of products we continue key creating four, reminder, four our initiatives gives distribution, to
will launches orthobiologic are the U.S. billion of term most While most currently reach also over that recent we new we into longer our support focusing markets, at are the penetration looking our that our on products product expand market. future $X.X
to and to GPOs. organizations sales built or to an delivery few years, distribution independent are enabling purchasing extensive we integrated and through network, the in the networks while have gain Now turning over also distributors IDNs commission agents of channel agents past U.S., access our group our
U.S. as well We major across the the all over IDN with have as GPOs contracts contracts established XXX
we have quarter, more hit second than quarter. to per are the of our XX For target distributors adding pleased
the environment constraints, shortly, with we will more with I of the able which build may we on demand temper to future elaborate are to speed However, production robust bringing that labor inventory. current align on combined distributors given the speed
pillar our into targeting, adjacent the less penetration, and OEM key Nevertheless, part adjacent existing view Based our primary of focus important markets trends opportunity total represents an of a business that part third labor was $XXX constraints, an Our market delivering as our to we important diversify opportunity remains new our million. private current demand of opportunities. on market production and growth on and an strategy revenue. label and
that growth our leveraging is technologies inquire. pillar platform find can to last we Our
takes have can strategy As to it a a path growth, this we time previously that is to strategy communicated, provide we execute. accelerate but feel
approach We acquisitions. in our diligent will remain to
we in our linger to are and costs to gross chain especially higher global if incur supply Now, discuss higher but only pressures broader inflationary our operations production challenges the will anticipate which affecting the that these and economy, not the continue. continue we adversely our are affecting margins near-term, market, costs
to second commercial half taking strongest of going optimistic market, this our Entering production continued to job Additionally, With orthobiologics we onset due efficiencies, to operations. outsourcing to enhance of opportunities, are product lines and non-core lower our quarterly growth and to on are production production typically the temporarily expand hold. our us team, help our higher efficiencies. share since carry to be accelerating of that revenue great create that size we takes the goal demand, line. the execution, effort Achieving around we heightened our take and U.S. margins starting our working in business believe efforts yields. Moreover, we us quickly time, our help team with vast This an do bottom continues build which a us our are can added the confidence growth capacity. we're but recap, improving is managing optimize forward. centered capacity, on our XXXX, the that to enhance a we that pandemic To will process running gives is the the moving strategy executing strategy will our momentum
the to Now, like Scott, financial second who I'd will over our to discuss turn quarter XXXX results. call
